- FoI Number
- 2024-255
- Subject
- Asthma
- Date Received
- 09/08/2024
- Request and Response
-
- How many patients have been treated (for any condition) in the last 4 months with:
Product
Number
Benralizumab
0
Dupilumab
<10
Omalizumab
<10
Reslizumab
0
Mepolizumab
0
Tezepelumab
0
Where we have given <10 answers, this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.
- Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups:
Age group
Number
Age 6-11
0
Age 12-17
<10
Age 18 and above
10
Where we have given <10 answers, this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.
- How many patients have been treated in the last 4 months by the Respiratory Medicine department ONLY with:
- Dupilumab
- Omalizumab
NHS Shetland does not have a Respiratory Medicine department.
